GETINGE An expanding Medical-Technology group with focus on comprehensive solutions for infection control, surgical systems and care of elderly and disabled.

Slides:



Advertisements
Similar presentations
April 28, Atlas Copco Group Q1 Results April 28, 2010.
Advertisements

Atlas Copco Group Q2 Results July 16, Contents  Q2 business highlights  Market development  Business areas  Financials  Outlook 2 July 16,
July 18, 2008, Atlas Copco Group Q2 Results July 18, 2008.
Atlas Copco Group Q4 Results February 2, Q4 - highlights  Order growth continued  Record operating profit –All business areas above 20% operating.
AGENDA  Cash flow  Balance sheet items  Currency effects  Quarterly earnings GETINGE GROUP.
Globalization of Mexican Businesses By Arun Kottolli.
GETINGE Acquisition of Boston Scientific’s Cardiac and Vascular Surgery Businesses.
GETINGE Acquisition of Datascope Corp.. 2 BUSINESS AREA INFECTION CONTROL HEALTHCARE Transaction Overview ____________________ (1)Exchange rate used for.
Acquisition of Jostra Group GETINGE has signed an agreement to purchase 100% of the shares of Jostra A.G. GETINGE will not acquire Jostra’s former US operations.
McBride plc : Interim Results 9 February 2006.
Leading engineering and expertise service company in industrial equipment segment Etteplan Oyj.
 Broad-based health care company that discovers, develops, manufactures, and markets products and services  Abbott's main businesses: ◦ Global pharmaceuticals.
The Health Care Sector Analysts: Heather Hund and Emily Butler.
Giving Your Business ESP SM Chris Andersen President 425 Market St., #2200 San Francisco, CA
GETINGE An expanding Medical-Technology group with focus on comprehensive solutions for infection control, surgical systems and care of elderly and disabled.
1 SAI Global Limited ABN: Half-Year Results Presentation Half-Year Ended 31 December 2006 ASX Code: SAI APPLIED INFORMATION SERVICES “SAI.
Hospital/Healthcare Provider Analysis 7/9/15. HCA owns and operates approximately 166 hospitals and approximately 113 freestanding surgery centers in.
Investor Relations Presentation September INVESTOR RELATIONS PRESENTATION - SEPTEMBER 2002 Agenda Introduction David Calverley Chief Executive Highlights.
► 1 Sustainable engineering & design. ◄ ► 2 Interim report January-September 2009 Operating profit of SEK million (436.6) Operating margin of 8.9.
Exel Oyj Interim Report January – March
GETINGE Capital Markets Day January 30 th, GETINGE... a rapidly expanding healthcare company.
Strategy Slide 1 © The Delos Partnership 2005 Dairygold Business Strategy & Status.
February 2, Atlas Copco Group Q4 Results February 2, 2010.
1 Full Year Results Presentation Full Year Ended 30 June 2006 ASX Code: SAI Thinking Business SAI Global Limited ABN:
GETINGE An expanding Medical-Technology group with focus on comprehensive solutions for infection control and care of elderly and disabled people CustomersAcute.
GEORGE WIMPEY PLC Interim Results GEORGE WIMPEY PLC st half results.
GETINGE GROUP GETINGE Capital Market Day February 1 st, 2006.
16 October The SKF Group Nine-month results 2008 Tom Johnstone, President and CEO.
M A K E Y O U R N E T W O R K S M A R T E R Focus on video boosts sales Summary of 2005 Ray Mauritsson, CEO.
 McBride plc Key Message Business Strategy has again delivered Full Year Profit, Cash and Dividends in line with market expectations.
Getinge Group. Shaping Health Care of tomorrow Net Sales10.9 billion SEK INFECTION CONTROL Production units10 Sales companies25 EXTENDED CARE Production.
1 COMPANY PRESENTATION OF THE FENIX OUTDOOR GROUP President Martin Nordin
AXIS Communications - a world of intelligent networks Full year 2002 CEO Peter Ragnarsson CFO Jörgen Lindquist.
1 The world’s leading manufacturer of collagen products for the food industry 2008 Interim Results Presentation 28 August 2008.
Tetra Acquisition Presentation March Forward Looking Statements This presentation includes forward-looking statements, which are based in part on.
Atlas Copco Group Q3 Results October 22, Q3 - highlights  Strong order growth –Sequentially higher volumes in all regions and in most customer.
April 27, Atlas Copco Group Q1 Results April 27, 2005.
July 17, Atlas Copco Group Q2 Results July 17, 2006.
Caring for the world, one person at a time… inspires and unites the people of Johnson & Johnson.
Lavendon Group plc 2006 Preliminary Results Presentation March 2007.
April 26, 2007, Atlas Copco Group Q1 Results April 26, 2007.
The Balanced Score Card
GETINGE GROUP Interim report January – March April 2012 Johan Malmquist, CEO Ulf Grunander, CFO.
BUSINESS AREA INFECTION CONTROL HEALTHCARE GETINGE GROUP A G E N D A  Cash flow  Balance sheet items  Currency effects.
GETINGE CAPITAL MARKETS DAY Johan Malmquist, CEO Boston 31 st of January 2012.
M A K E Y O U R N E T W O R K S M A R T E R Strong trend for Network Video continues January - March 2006 Ray Mauritsson, CEO.
GETINGE GROUP Year end report January – December January 2012 Johan Malmquist, CEO Ulf Grunander, CFO.
Getinge overview An expanding Medical-Technology group with focus on comprehensive solutions for infection control, surgical systems and care of elderly.
Atlas Copco Group Q3 Results October 23, Page 2 October 23, 2001www.atlascopco-group.com Contents  Market Development  Business Areas  Financials.
July 16, 2007, Atlas Copco Group Q2 Results July 16, 2007.
Atlas Copco Group Q3 Results October 21, Q3 - highlights  Overall demand remained at a high level –Solid development in manufacturing and mining.
Atlas Copco Group Q1 Results Stockholm, April 26, 2001.
 Products, Customers, Geography, and Stages  Industry vs. Market  Does industry matter?
Group Handout Atlas Copco Group – September 30 th 2000 The face of interaction.
Giulio Mazzalupi Atlas Copco Group - Q4 Results Stockholm, February 12, 2001.
Index Group Handout Atlas Copco Group – June 30 th 2000 The face of interaction.
 McBride plc Strategic Objectives Build No 1 Private Label household & personal care position Be Retail Partner of choice Improve operational.
The SKF Group Half-year result 2003 Tom Johnstone President and CEO.
INTERNATIONAL MARKETING MANAGEMENT SESSION 13: GLOBAL PORTFOLIO STRATEGY 1.
Telephone conference July 13th Page 2 CEO comment to the half-year report ”During the first half of the year we achieved results before restructuring.
Oppenheimer Industrial Growth Conference May 14, 2014.
INTERIM REPORT FOR Q3 2009/10 By CEO Lars Marcher and CFO Anders Arvai.
Andy Passey September 23rd 2003 Advanced Wound Management in Europe: Market Overview and Critical Success Factors © 2003 Frost & Sullivan. All rights reserved.
Telephone conference May 16th Page 2 CEO comment to the Q1 Report ”The first Quarter of 2012 was characterised by a strong recovery after the difficult.
Q2 Results Stockholm, July 19, 2001
Maquet in brief Net sales 99/ M EUR Employees 1 300
KORRES GROUP 9M 2014 FINANCIAL RESULTS
First Half FY 2018 Operating and Financial Results
Atlas Copco Group Q3 Results October 22, 2010.
GETINGE GROUP Year end report January – December January 2012
Presentation transcript:

GETINGE An expanding Medical-Technology group with focus on comprehensive solutions for infection control, surgical systems and care of elderly and disabled people Customers Net Sales Associates Manufacturing Distribution Acute Care Long term care Industry/Laboratories 8.1 billion SEK production units in 9 countries 80 sales companies in 25 countries Distributors in I00 countries

Infection Control Sterilization Disinfection40% Industry I0% Acute care 60% Long term care 30% Surgical Systems Surgical tables Surgical lamps30% Business Scope Extended Care Hygiene Systems Patient Handling Wound Care30%

Getinge Group Objectives Financial To increase profit before tax with an average of I5% per annum To increase profit before tax with an average of I5% per annum Internally generated cash flow to sustain an external growth rate of I0% per annum Internally generated cash flow to sustain an external growth rate of I0% per annum Strategic To develop world leading positions in prioritized niches of the health care industry To develop world leading positions in prioritized niches of the health care industry

Infection Control To create a customer focused group from a federation of companies acquired over the last I0 years Extended Care Focus on growth from a solid platform through product innovation, market penetration and geographical expansion Surgical Systems To create a global leader in the field of surgical work stations as a platform for further growth in the surgical systems market Group Focus

Business Area Extended Care Patient Handling Hygiene Systems Complete solutions for institutional extended care: Nursing Homes, Hospitals, Assisted Living Wound Care

Strategic Cornerstones Product leadership Product leadership Complete solutions Complete solutions Positive outcomes Positive outcomes

Extended Care Market development Q1 (msek)

Extended Care Results Q1 (msek)

Business area Infection Control Health Care DisinfectionIT-solutionsSterilization Load handling Complete Systems for: Central Processing Departments, Outpatient Surgery, Wards, Infectious Waste, Microbiology, Pharmacies

Load Handling WashingSterilization Water Treatment Complete Systems for: Production, Research / Laboratories, Animal Care Facilities, Food Industry Business area Infection Control Industry

Moving up the Value chain Service Provider Concept Complete Infection Control Solution SterilizerDisinfector Load handling LogisticsConsumables Information Management After Sales service EducationSterilizerDisinfector Load handling LogisticsConsumables Information Management After Sales service Education

Strategic Cornerstones Cost leadership Cost leadership Complete solutions Complete solutions Service infrastructure Service infrastructure

Position the Getinge brand as a competent solutions provider Position the Getinge brand as a competent solutions provider Improved production structure Improved production structure Organizational focus Organizational focus Increased focus on R & D - low temp solutions Increased focus on R & D - low temp solutions - material handling - material handling - ergonomy - ergonomy Service expansion Service expansion Key Activities

Infection Control Market development Q1 (msek)

Infection Control Results Q1 (msek)

Business area Surgical Systems Surgical Lights Surgical Tables Ceiling Service Systems Ceiling Service Systems Integrated Solutions for Surgical Workstations and ICU’s

Strategic Cornerstones Technological leadership Technological leadership Integrated solutions Integrated solutions Excellence in service Excellence in service

Production Closure of production facilities in Charleston USA and Oer-Erkenschwick Germany Distribution Merger of sales activities in Germany, USA, UK, France, Italy, Spain, Japan and International Reduced overhead costs Synergies of I40 - I50 MSEK annually from 2002 Restructuring Program Divestiture of OrtoMaquet

Product development initiatives Product development initiatives Market penetration tables USA + Japan Market penetration tables USA + Japan I5 --> 30% market shares --> 250 MSEK+ I5 --> 30% market shares --> 250 MSEK+ Cross-selling opportunities in most markets Cross-selling opportunities in most markets Own sales companies in major markets Own sales companies in major markets Active participation in the consolidation of the surgical systems market Active participation in the consolidation of the surgical systems market Growth Opportunities in Surgical Systems

Surgical systems Market development Q1 (msek)

Surgical Systems Results Q1 (msek)

Getinge AB Results (Msek)

Getinge AB Balance sheets (Msek)

Turnaround in the earnings trend for Infection Control Turnaround in the earnings trend for Infection Control Good overall order situation and market outlook for all business areas Good overall order situation and market outlook for all business areas Incremental synergies in Surgical Systems Incremental synergies in Surgical Systems Improving capital utilization Improving capital utilization Getinge is well positioned Short term

Strong market fundamentals in Extended Care Strong market fundamentals in Extended Care Significant scope for improvement in operating performance within Infection Control Significant scope for improvement in operating performance within Infection Control Opportunities for growth through acquisitions in a fragmented Surgical Systems market Opportunities for growth through acquisitions in a fragmented Surgical Systems market Getinge is well positioned Long term